iRay Group (SHA:688301)
China · Delayed Price · Currency is CNY 88.20
+2.41 (2.81%)
Jul 25, 2025, 2:45 PM CST
iRay Group Revenue
iRay Group had revenue of 481.51M CNY in the quarter ending March 31, 2025, a decrease of -1.92%. This brings the company's revenue in the last twelve months to 1.82B, down -4.82% year-over-year. In the year 2024, iRay Group had annual revenue of 1.83B, down -1.74%.
Revenue (ttm)
1.82B
Revenue Growth
-4.82%
P/S Ratio
9.69
Revenue / Employee
884.89K
Employees
2,059
Market Cap
17.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.83B | -32.39M | -1.74% |
| Dec 31, 2023 | 1.86B | 314.67M | 20.31% |
| Dec 31, 2022 | 1.55B | 361.76M | 30.47% |
| Dec 31, 2021 | 1.19B | 403.27M | 51.43% |
| Dec 31, 2020 | 784.08M | 237.97M | 43.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |